Real time Form 13D and 13G transaction reports:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
- Shares have beem adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
| Reported DateTime |
Transaction Date |
Type | Company Symbol |
Filed By Symbol |
Shares Owned % Owned |
Shares Vs. Prev Report | View |
| 2025-02-13 1:50 pm Purchase |
2024-12-31 | 13G | Imunon, Inc. IMNN |
Ayrton Capital LLC | 1,250,000 7.900% |
1,250,000 (New Position) |
Filing History |
| 2025-02-13 1:47 pm Sale |
2024-12-31 | 13G | Trio Petroleum Corp. TPET |
Ayrton Capital LLC | 38,496 0.100% |
-199,875 (-83.85%) |
Filing History |
| 2025-02-13 1:46 pm Sale |
2024-12-31 | 13G | ToughBuilt Industries, Inc. TBLT |
Ayrton Capital LLC | 65,812 4.400% |
-4,031,322 (-98.39%) |
Filing History |
| 2025-02-13 1:44 pm Sale |
2024-12-31 | 13G | Petros Pharmaceuticals, Inc. PTPI |
Ayrton Capital LLC | 657,614 6.200% |
-15,296 (-2.27%) |
Filing History |
| 2025-02-13 1:42 pm Sale |
2024-12-31 | 13G | PharmaCyte Biotech, Inc. PMCB |
Ayrton Capital LLC | 774,100 9.900% |
-182,129 (-19.05%) |
Filing History |
| 2025-02-13 1:40 pm Purchase |
2024-12-31 | 13G | PAVmed Inc. PAVM |
Ayrton Capital LLC | 1,226,316 9.900% |
375,298 (+44.10%) |
Filing History |
| 2025-02-13 1:38 pm Sale |
2024-12-31 | 13G | Lucid Diagnostics Inc. LUCD |
Ayrton Capital LLC | 1,200,485 2.000% |
-3,755,213 (-75.78%) |
Filing History |
| 2025-02-13 1:35 pm Sale |
2024-12-31 | 13G | KWESST Micro Systems Inc. KWE |
Ayrton Capital LLC | 118,500 7.000% |
-1,066,500 (-90.00%) |
Filing History |
| 2025-02-13 1:33 pm Unchanged |
2024-12-31 | 13G | SeaStar Medical Holding Corporation ICU |
Ayrton Capital LLC | 294,361 6.200% |
0 (Unchanged) |
Filing History |
| 2025-02-13 1:32 pm Unchanged |
2024-12-31 | 13G | Genius Group Limited GNS |
Ayrton Capital LLC | 1,953,162 8.300% |
0 (Unchanged) |
Filing History |
| 2025-02-13 1:23 pm Purchase |
2024-12-31 | 13G | Arcimoto, Inc. FUVV |
Ayrton Capital LLC | 945,930 9.900% |
945,930 (New Position) |
Filing History |
| 2025-02-13 1:20 pm Unchanged |
2024-12-31 | 13G | China Natural Resources, Inc. CHNR |
Ayrton Capital LLC | 557,951 5.400% |
0 (Unchanged) |
Filing History |
| 2025-02-13 1:17 pm Purchase |
2024-12-31 | 13G | Addentax Group Corp. ATXG |
Ayrton Capital LLC | 646,542 9.900% |
215,139 (+49.87%) |
Filing History |
| 2025-02-13 1:14 pm Purchase |
2024-12-31 | 13G | Tritium DCFC Limited DCFC |
Ayrton Capital LLC | 18,777,000 9.900% |
18,685,060 (+20323.21%) |
Filing History |
| 2025-02-13 1:11 pm Purchase |
2024-12-31 | 13G | Ocean Biomedical, Inc. OCEA |
Ayrton Capital LLC | 3,873,632 9.900% |
91,866 (+2.43%) |
Filing History |
| 2025-02-13 1:07 pm Purchase |
2024-12-31 | 13G | Traws Pharma, Inc. TRAW |
Ayrton Capital LLC | 403,650 9.900% |
403,650 (New Position) |
Filing History |
| 2025-02-13 1:05 pm Purchase |
2024-12-31 | 13G | The Glimpse Group, Inc. VRAR |
Ayrton Capital LLC | 1,860,380 9.900% |
1,860,380 (New Position) |
Filing History |
| 2025-02-13 1:03 pm Purchase |
2024-12-31 | 13G | Sidus Space, Inc. SIDU |
Ayrton Capital LLC | 724,638 8.400% |
724,638 (New Position) |
Filing History |
| 2025-02-13 1:01 pm Purchase |
2024-12-31 | 13G | 180 Life Sciences Corp. ATNF |
Ayrton Capital LLC | 334,742 9.900% |
334,742 (New Position) |
Filing History |
| 2024-11-14 5:37 pm Purchase |
2024-09-30 | 13G | Imunon, Inc. CLSN |
Ayrton Capital LLC | 1,054,438 9.900% |
684,068 (+184.70%) |
Filing History |